Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pre-clinical crawled date : 2020 - 12 - 01 save search
Onconova Therapeutics Announces Publication of Preclinical Data Supporting Rigosertib’s Mechanism of Action as a Targeted Anticancer Therapy
Published: 2020-07-23 (Crawled : 22:15) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: 6.72%
H: 2.36%
C: -10.24%
therapy cancer preclinical pre-clinical
Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential deal value of €875 million, plus royalties
Published: 2020-07-08 (Crawled : 22:14) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.04%
H: 0.39%
C: 0.21%
license royalties potential preclinical pre-clinical
Aptevo Therapeutics to Present New Preclinical Data for APVO436 and ALG.APV.527 at the American Association for Cancer Research 2019 Annual Meeting
Published: 2019-03-25 (Crawled : 22:14) - globenewswire.com
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: 2.2%
H: 10.75%
C: 4.38%
cancer research preclinical apvo436 alg.apv-527 pre-clinical
Aptevo Therapeutics Presents New Preclinical Data for APVO436 and ALG.APV-527 at the American Association for Cancer Research 2019 Annual Meeting
Published: 2019-04-02 (Crawled : 22:14) - globenewswire.com
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: 5.29%
H: 0.0%
C: -6.49%
cancer research preclinical apvo436 alg.apv-527 pre-clinical
Aptevo Therapeutics and Alligator Bioscience Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer 2019 Annual Meeting
Published: 2019-11-08 (Crawled : 22:14) - globenewswire.com
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: 3.52%
H: 6.97%
C: 3.74%
cancer therapy immunotherapy preclinical alg.apv-527 pre-clinical
CEL-SCI’s LEAPS Peptides Demonstrate Clear Survival Benefit as a Treatment for COVID-19 in Preclinical Studies
Published: 2020-12-01 (Crawled : 22:01) - biospace.com/
CVM | $1.56 4.0% 0.0% 230K
|
Health Technology
|
| O: 1.44%
H: 2.05%
C: -3.15%
covid treatment preclinical cel pre-clinical
Cidara Therapeutics to Present Preclinical Data for Influenza AVCs at the 7th ESWI Influenza Conference
Published: 2020-12-01 (Crawled : 22:00) - biospace.com/
CDTX | $0.6855 -5.06% -5.32% 350K
|
Health Technology
|
| O: 2.14%
H: 0.0%
C: -9.21%
influenza preclinical pre-clinical
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.